drugset / Trial / NCT03314402
The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomized, double-blinding, dose-escalated phase 1 trial to evaluate the tolerance and fasting/postprandial pharmacokinetics of jaktinib.
Timeline
- Start
- 2017-09-28
- Primary completion
- 2018-08-30
- Completion
- 2018-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jaktinib | Unknown | — | Oral |
Indications
No indication recorded.